Navigation Links
Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties
Date:9/28/2010

BURLINGTON, Mass., Sept. 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that oncologists will be the most aggressive in adopting biosimilars compared with other specialties because of their lower clinical trial requirements. According to Biosimilars Advisory Service: Physician Perspectives on Biosimilar G-CSFs and MAbs in Oncology, Decision Resources expects biosimilar versions of granulocyte colony-stimulating factor (G-CSF) and monoclonal antibody (MAb) therapies used in oncology to erode more than $7 billion in brand sales in 2019 alone across the U.S., EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan markets.

Primary research reveals U.S oncologists in particular will more rapidly adopt biosimilars compared to their European counterparts. Compared with French and German oncologists, U.S. oncologists will require fewer and shorter Phase III clinical trials before they feel comfortable prescribing biosimilars. The majority of surveyed U.S. oncologists would require one trial lasting 12 months or less for biosimilar G-CSFs and at most two clinical trials lasting two years or less for biosimilar MAbs before they feel comfortable prescribing biosimilars. Surveyed solid-tumor oncologists across countries have higher expectations for clinical trials of biosimilar MAbs than for biosimilar G-CSFs.

Across the U.S., France and Germany, the majority of surveyed oncologists expect to begin prescribing biosimilars within 12 months after launch, contributing to the rapid erosion of branded G-CSFs and MAbs.

"Because of patent expiries and more established regulatory pathways for approving biosimilars in Europe, most biosimilar MAbs will launch in the EU5 before the United States," said Decision Resources Analyst Cindy Fung, Ph.D. "As a r
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
4. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
5. Society of Gynecologic Oncologists 40th Annual Meeting on Womens Cancer to Include Sessions on Robotics Surgery
6. SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
7. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
8. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
9. US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology
10. For Treatment of Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabTheras Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Luminex Corporation (NASDAQ: LMNX ... Morgan Stanley Global Healthcare Conference to be held September ... in New York City . ... Eastern time on Friday, September 18, 2015.  The presentation ... Corporation,s website at http://www.luminexcorp.com . Simply log on to ...
(Date:9/4/2015)... , Sept. 4, 2015  Cumberland Pharmaceuticals (CPIX), ... will present live at VirtualInvestorConferences.com on September 10, 2015. ... 2:30p.m. ET LINK: http://tinyurl.com/sep10pre ... where investors are invited to ask the company questions ... well as the association,s "virtual trade booth." If attendees ...
(Date:9/4/2015)... , Sep. 04, 2015 ... announced the addition of the "Pharmacovigilance (London, ... their offering. Understanding PhV today - ... those working in Drug safety. This ... concerned with pharmacovigilance. New entrants as well as ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2
... , , SALT LAKE CITY, Nov. 17 ... (WorldHeart) announced today that it has finalized assignment and ... California, and Carnegie Mellon University (CMU), Pittsburgh, Pennsylvania for ... MiVAD(TM) is designed to provide partial cardiac support between ...
... Calif., Nov. 17 Three out of four mothers ... 12 are extremely, very, or somewhat concerned about their ... conducted by Opinion Research Corporation and commissioned by Bionorica, ... including Sinupret® for Kids, a product which supports healthy ...
Cached Medicine Technology:WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump 2WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump 3Survey Finds Mothers Take Children's Health Into Their Own Hands 2Survey Finds Mothers Take Children's Health Into Their Own Hands 3Survey Finds Mothers Take Children's Health Into Their Own Hands 4
(Date:9/4/2015)... Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... Program was ranked number 9 nationwide by Doximity. Faculty, residents and staff ... we take great pride in the quality of our ophthalmology residency program. Our faculty ...
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor ... to an increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to ... country’s health bill. Fortunately, a solution to alleviate this problem has recently presented itself, ...
(Date:9/4/2015)... New York, NY (PRWEB) , ... September 04, 2015 , ... ... 400 meters qualifying heat, and followed up with victory in the men’s 400 meters ... Caribbean (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August ...
(Date:9/4/2015)... ... 2015 , ... Compliance officers deal with many high-risk issues, ... self-referral law. “Stark Law DOs and DON’Ts: Best Practices for Your Physician ... will detail which deals are attracting the most government scrutiny and what are ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the online retail ... cannot be passed up. FiltersFast.com, will ship all orders over $50.00 for ... product replacements. Take advantage of this promotion now through September 8, 2015. , ...
Breaking Medicine News(10 mins):Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... a planned light rail line in the Twin Cities would ... the people in the communities it would pass through, according ... TakeAction Minnesota, and ISAIAH, a nonprofit coalition of 90 congregations ... Cloud region. The HIA was made possible through a grant ...
... WEDNESDAY, Jan. 4 (HealthDay News) -- People who lack the ... are more likely to be aggressive when they,re drunk, a ... and now, without thinking about the impact on the future, ... the effect is magnified greatly when they,re drunk," study author ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- Physicians need ... patients to prevent harmful interactions between drugs, experts ... of Neurology (AAN) has led to the issuance of ... with the International League Against Epilepsy. "It is ...
... 4, 2012 -- ,CHAPEL HILL People with high cholesterol ... plaques within their arteries can rupture triggering the formation of ... the blood supply to their heart or brain. ... clotting. Now, a study led by researchers from the University ...
... , WEDNESDAY, Jan. 4 (HealthDay News) -- Men appear more ... Asians with the neurologic disorder, a large U.S. study reveals. ... from dementia had a higher death rate from Parkinson,s disease. ... patients across the United States who were Medicare beneficiaries between ...
... rotovirus vaccine was pulled from the marketplace in 1999 ... updated rotavirus vaccines do not appear to increase the ... a new study by child health experts at C.S. ... the vaccine,re-introduced in 2006 and 2008, prevent infection by ...
Cached Medicine News:Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 2Health News:Twin Cities light rail project presents both opportunities and risks for health, according to report 3Health News:Study Reveals Who's More Prone to Be a 'Mean Drunk' 2Health News:New Guidelines Issued for Combining HIV, Seizure Meds 2Health News:Benefits of statin therapy may extend beyond lowering lipids 2Health News:Race, Gender, Dementia May Affect Parkinson's Survival 2Health News:U-M study shows updated rotavirus vaccine not linked to increase in bowel obstruction 2
... Agarose 3:1 HRB™ (High Resolution Blend), is ... provide high resolution of small nucleic acids ... of DNA fragmanets less than 1,000 bp. ... without smearing of high background fluorescence. The ...
... is specifically formulated for high resolution of ... bp. This standard melting temperature agarose can ... 10 bp difference in size. UltraPure™ ... structure for better handling and improved clarity ...
... low electroendosmosis (EEO) is ... applications. If separated nucleic ... used as substrates for ... restriction endonucleases, a special ...
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Medicine Products: